August 6, 2014
The FDA’s first biosimilar approval application has stirred high hopes among some members of the health care community – and heated debate among others.
August 5, 2014
Real world data (RWD) provides valuable insight for improving health care, a new report from the Galen Institute contends.
July 31, 2014
Natural disasters can leave community members scrambling for shelter, clean water, food – and their prescription medications.
July 29, 2014
The American Academy of Pediatrics’ new guidelines on RSV treatment, announced yesterday, sparked immediate and ardent debate, pitting premature babies’ families and care providers against the AAP in a showdown about who deserves preventative care.
July 25, 2014
An opponent to distinct names for biosimilar medications has petitioned the Food and Drug Administration with a new argument: Same old, same old works just fine.
July 23, 2014
For patients waiting on medical advances to improve their lives, public-private research partnerships may present a more efficient alternative to traditional research.
July 21, 2014
Patients who had hoped to attain comprehensive health care coverage through the Affordable Care Act may be discovering yet another roadblock to treatment.
July 17, 2014
State by state, the U.S. is enacting better health policy on the issue of pain management.
July 14, 2014
Claritin, Zantac, the nicotine patch – even children’s Advil – were once accessible only by prescription.
July 10, 2014
Innovation, data sharing and public-private partnerships could help modernize clinical trials, agreed witnesses at Wednesday’s “21st Century Cures” hearing by the House Energy and Commerce Committee Health Subcommittee.
